• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性血管性水肿患者的危及生命的喉部发作

Life-threatening laryngeal attacks in hereditary angioedema patients.

作者信息

Piotrowicz-Wójcik Katarzyna, Porebski Grzegorz

机构信息

Zakład Alergologii Klinicznej i Środowiskowej, Uniwersytet Jagielloński Collegium Medicum w Krakowie.

出版信息

Otolaryngol Pol. 2020 Mar 31;74(2):1-5. doi: 10.5604/01.3001.0014.0619.

DOI:10.5604/01.3001.0014.0619
PMID:32308206
Abstract

BACKGROUND

Hereditary angioedema due to C1-inhibitor deficiency (HAE-C1INH) is a rare genetic disease that runs in the family. As a result of the disease, acute swellings of the subcutaneous tissue and mucous membranes of the digestive and respiratory systems, including the larynx, occur. Any attack of the disease involving the throat and larynx is particularly dangerous and requires knowledge of clinical determinants of the disease and its proper management.

MATERIALS AND METHODS

The study included adult consecutive HAE-C1INH patients having follow-up visits in our centre. The group was examined with a structured clinical questionnaire, concerning the last 6 months and focusing particularly on laryngeal swelling attacks.

RESULTS

55 subjects (F/M - 35/20, age range - 18-76) were included in the study. Laryngeal attacks occurred in 19 individuals (34.5%): 1-3, 4-6, and ≥7 attacks in 9, 8 and 2 patients, respectively, two of whom required intubation. In comparison to other patients, subjects with laryngeal attacks were characterised by significantly more frequent: (1) facial attacks, (2) severe disease activity, (3) the occurrence of female patients, (4) mental stress as a trigger of attacks. All patients with laryngeal attacks had a rescue medication at home and 15/19 (78%) patients could use it at home. Most of them used plasma-derived C1-inhibitor 17/19 (89.5%) and icatibant, 8/19 (42.1%).

DISCUSSION

HAE-C1INH patients with laryngeal attacks require particular attention. Proper training regarding the identification of these patients, adequate management, access to emergency services and emergency drugs are essential to ensure the safety of subjects with this localization of HAE-C1INH attacks.

摘要

背景

C1抑制物缺乏所致遗传性血管性水肿(HAE-C1INH)是一种家族性罕见遗传病。该病会导致皮下组织以及包括喉部在内的消化和呼吸系统黏膜急性肿胀。该病任何累及咽喉部的发作都特别危险,需要了解疾病的临床决定因素并进行恰当管理。

材料与方法

该研究纳入了在我们中心进行随访的成年连续性HAE-C1INH患者。采用结构化临床问卷对该组患者进行检查,问卷涉及过去6个月的情况,尤其关注喉部肿胀发作情况。

结果

该研究纳入了55名受试者(女性/男性 - 35/20,年龄范围 - 18至76岁)。19名个体(34.5%)发生过喉部发作:9名、8名和2名患者分别发作1 - 3次、4 - 6次和≥7次,其中两名患者需要插管。与其他患者相比,发生喉部发作的受试者具有以下显著更频繁的特征:(1)面部发作,(2)疾病活动严重,(3)女性患者的出现,(4)精神压力作为发作诱因。所有发生喉部发作的患者家中都备有急救药物,19名患者中有15名(78%)在家中能够使用。他们中的大多数使用血浆源性C1抑制物,19名中有17名(89.5%),使用依卡替班的有8名(42.1%)。

讨论

发生喉部发作的HAE-C1INH患者需要特别关注。对这些患者进行关于识别、恰当管理、获得急救服务和急救药物的适当培训,对于确保HAE-C1INH发作定位于此的患者的安全至关重要。

相似文献

1
Life-threatening laryngeal attacks in hereditary angioedema patients.遗传性血管性水肿患者的危及生命的喉部发作
Otolaryngol Pol. 2020 Mar 31;74(2):1-5. doi: 10.5604/01.3001.0014.0619.
2
Hereditary angioedema: management of laryngeal attacks.遗传性血管性水肿:喉部发作的管理。
Am J Rhinol Allergy. 2011 Nov-Dec;25(6):379-82. doi: 10.2500/ajra.2011.25.3670.
3
Pathophysiology of hereditary angioedema.遗传性血管性水肿的病理生理学。
Am J Rhinol Allergy. 2011 Nov-Dec;25(6):373-8. doi: 10.2500/ajra.2011.25.3661.
4
Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey.获得性血管性水肿与遗传性血管性水肿(I/II型)的比较:依卡替班疗效调查结果
Clin Exp Immunol. 2017 Apr;188(1):148-153. doi: 10.1111/cei.12910. Epub 2017 Feb 9.
5
The Icatibant Outcome Survey: treatment of laryngeal angioedema attacks.依卡替班疗效调查:喉血管性水肿发作的治疗
Eur J Emerg Med. 2016 Jun;23(3):224-7. doi: 10.1097/MEJ.0000000000000292.
6
Therapeutic management of hereditary angioedema due to C1 inhibitor deficiency.遗传性血管性水肿(C1 抑制剂缺乏症)的治疗管理。
Expert Rev Clin Immunol. 2013 May;9(5):477-88. doi: 10.1586/eci.13.22.
7
Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.妊娠期采用艾替班特和重组 C1 抑制剂治疗遗传性血管性水肿发作。
J Clin Immunol. 2018 Oct;38(7):810-815. doi: 10.1007/s10875-018-0553-4. Epub 2018 Oct 2.
8
Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.遗传性血管性水肿伴正常 C1 抑制剂:法国队列的临床特征和依替巴肽治疗反应。
Immun Inflamm Dis. 2017 Jan 11;5(1):29-36. doi: 10.1002/iid3.137. eCollection 2017 Mar.
9
Content validity of visual analog scales to assess symptom severity of acute angioedema attacks in adults with hereditary angioedema: an interview study.评估成人遗传性血管性水肿急性发作症状严重程度的视觉模拟评分的内容效度:一项访谈研究。
Patient. 2012;5(2):113-26. doi: 10.2165/11597490-000000000-00000.
10
Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial.在 FAST-1 试验中开放性使用艾替班特治疗急性遗传性血管性水肿发作的重复治疗。
Clin Exp Immunol. 2014 Aug;177(2):544-53. doi: 10.1111/cei.12358.

引用本文的文献

1
Attack frequency and associated factors in hereditary angioedema patients: a single-centre experience.遗传性血管性水肿患者的发作频率及相关因素:单中心经验
Postepy Dermatol Alergol. 2025 Feb;42(1):75-82. doi: 10.5114/ada.2024.144488. Epub 2024 Nov 6.
2
Neurologic and Psychiatric Manifestations of Bradykinin-Mediated Angioedema: Old and New Challenges.缓激肽介导的血管性水肿的神经和精神表现:旧的和新的挑战。
Int J Mol Sci. 2023 Jul 29;24(15):12184. doi: 10.3390/ijms241512184.
3
The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update.
国际血管性水肿学会(WAO)/欧洲变态反应和临床免疫学会(EAACI)遗传性血管性水肿管理指南——2021年修订与更新
World Allergy Organ J. 2022 Apr 7;15(3):100627. doi: 10.1016/j.waojou.2022.100627. eCollection 2022 Mar.